Severe maternal morbidity and near misses in tertiary hospitals, Kelantan, Malaysia: a cross-sectional study

BMC Public Health

Table 7 Process indicators

Process indicator	SMM		MNM
Process indicator	Target population	n (%)	Target population	n (%)
Prevention of postpartum haemorrhage^a	363	361 (99.4)	42	41 (97.6)
Treatment of severe postpartum haemorrhage^b	210	208 (99.0)	26	25 96.2)
Anticonvulsants for eclampsia^c	22	22 (100.0)	2	2 (100.0)
Prevention of severe systemic infections or sepsis^d	286	282 (98.6)	35	35 (100.0)
Treatment of severe infections and sepsis^e	2	2 (100.0)	0

SMM severe maternal morbidity, MNM maternal near miss
^aThe number of women who received a single dose of oxytocin for the prevention of postpartum haemorrhage divided by the number of all women giving birth
^bThe number of women with postpartum haemorrhage who received therapeutic oxytocin divided by the number of all women with postpartum haemorrhage
^cThe number of women with eclampsia who received magnesium sulfate divided by the number of all women with eclampsia
^dThe number of women having a caesarean section and receiving prophylactic antibiotics divided by the number of all women having caesarean sections
^eThe number of women with severe systemic infections or sepsis who received antibiotics divided by the number of all women with severe systemic infections or sepsis

ISSN: 1471-2458